Table 1. Clinical characteristics of patients.
| Characteristics | Alive (n=63)n (%) | Deceased (n=42) n (%) | p value |
|---|---|---|---|
| Median age (range) | 49 (25-85) | 61 (18-92) | 0.013* |
| Male | 4 (20) | 16 (80) | <0.001* |
| Female | 58 (68.2) | 27 (31.8) | <0.001* |
| Chronic lung disease | 2 (1.9) | 3 (2.9) | 0.07* |
| Comorbidities | |||
| DM | 12 (11.4) | 10 (9.5) | 0.23* |
| Hypertension | 22 (20.9) | 18 (17.1) | 0.44* |
| CHF | 3 (2.9) | 4 (3.8) | 0.81* |
| Symptoms | |||
| Fever | 20 (19) | 12 (11.4) | 0.63† |
| Cough | 26 (24.7) | 14 (13.3) | 0.33† |
| Dyspnea | 16 (15.2) | 32 (30.4) | <0.001† |
| Fatigue | 10 (9.5) | 4 (3.8) | 0.31† |
| Myalgia | 13 (12.3) | 1 (0.9) | 0.007† |
| Anosmia | 6 (5.7) | 0 | 0.07† |
| Solid tumors | 61 (58) | 39 (37.1) | 0.08* |
| Breast | 27 (25.7) | 11 (10.4) | |
| Genitourinary | 2 (1.9) | 5 (4.7) | |
| Gastrointestinal | 5 (4.7) | 4 (3.8) | |
| Gynecologic | 23 (21.9) | 12 (11.4) | |
| Lung | 3 (2.8) | 0 | |
| Skin, non-melanoma | 0 | 3 (2.8) | |
| Head and neck | 1 (0.9) | 4 (3.8) | |
| Hematologic malignancies | 1 (0.9) | 4 (3.8) | |
| Metastatic disease | 0.005* | ||
| No | 34 (32.3) | 11 (10.4) | |
| Yes | 28 (28.6) | 32 (30.4) | |
| Performance status (ECOG) | 0.0001* | ||
| 0-1 | 35 (33.6) | 7 (6.7) | |
| 2-4 | 27 (25.9) | 35 (33.6) | |
| Do-not-resuscitate | 0.048* | ||
| No | 54 (51.4) | 31 (29.5) | |
| Yes | 8 (7.6) | 12 (11.4) | |
| Active chemotherapy | 0.518* | ||
| No | 45 (42.8) | 28 (26.6) | |
| Yes | 17 (16.1) | 15 (14.2) | |
| Active radiotherapy | 0.714* | ||
| No | 58 (55.2) | 39 (37.1) | |
| Yes | 4 (3.8) | 4 (3.81) | |
| Recent surgery | 0.661* | ||
| No | 46 (43.8) | 30 (28.5) | |
| Yes | 16 (15.2) | 13 (12.3) |
Age stated as median and range. Other variables stated as absolute numbers and percent.
* χ2 test; † Student’s t test.
DM: diabetes mellitus; CHF: congestive heart failure; ECOG: Eastern Cooperative Oncology Group.